Diversion Control Division, US Department of Justice, Drug Enforcement Administration

RESOURCES > Publications & Manuals > Press Releases

Press Releases

DEA’s Diversion Control Division strives to prevent, detect, and investigate the diversion of controlled pharmaceuticals and listed chemicals from legitimate sources. When the safety and health of the American people is in jeopardy, DEA takes action against those who violate the law. Read the latest on these enforcement cases and civil actions.

May 2023

Nurse Who Stole Painkillers, Replacing Them with Saline and Putting Surgical Patients at Risk, Sentenced to Four Years (May 22, 2023)

Denton Physician Sentenced for Over-Prescribing Opioids (May 19, 2023)

Levittown, Pennsylvania Physician Agrees to Pay $100,000 to Resolve Controlled Substances Act Violations (May 18, 2023)

Wisconsin Naturopathic Practitioner Sentenced to Twelve Months' Imprisonment for Unlawful Prescribing of Controlled Substances (May 15, 2023)

Communities Across the Country Remove Nearly 664,000 Pounds of Unneeded Prescription Medications to Prevent Drug Misuse (May 15, 2023)

Former Modesto Doctor Pleads Guilty to Illegally Prescribing Opioids (May 11, 2023)

East Windsor Man Sentenced to Prison for Oxycodone Prescription Fraud Scheme (May 11, 2023)

DEA, SAMHSA Extend COVID-19 Telemedicine Flexibilities for Prescribing Controlled Medications for Six Months While Considering Comments from the Public (May 09, 2023)

April 2023

Former Paramedic Sentenced to Three Years in Prison for Stealing Medical-Grade Fentanyl (April 28, 2023)

New Jersey Doctor Admits Health Care Fraud Targeting Amtrak (April 26, 2023)

Physician and Clinic Office Manager Convicted of Unlawfully Distributing Over 600,000 Opioid Pills (April 12, 2023)

Providence Man Indicted for Selling Oxycodone to Undercover Officer (April 11, 2023)

Santa Rosa Doctor Sentenced to More than Two Years in Prison for Unlawfully Prescribing Fentanyl and Oxycodone (April 9, 2023)

March 2023

Former Health Care Worker Sentenced for Fentanyl Thefts (March 29, 2023)

Colorado Pharmacy and Pharmacist Agree to Resolve Allegations that They Unlawfully Filled Dangerous Prescriptions for Controlled Substances (March 27, 2023)

Indianapolis Pharmacy Technician Charged with Controlled Substances Violations (March 24, 2023)

Panama City Physician Pays $225,000 to Settle Allegations that He Overprescribed Controlled Substances (March 21, 2023)

Exton, Pennsylvania Lab Agrees to Pay $125,000 to Resolve Controlled Substances Act Violations (March 17, 2023)

Former Nurse Sentenced for Stealing Opioids from Kansas Hospital (March 13, 2023)

Defendants Convicted and Sentenced in Long-Term Methamphetamine and Oxycodone Drug Trafficking Investigation in Bay County (March 10, 2023)

Nurse at St. Louis County Hospital Sentenced to Four Years of Probation for Fraudulently Obtaining Fentanyl (March 09, 2023)

Greenwood Village Psychiatrist Pleads Guilty to Illegal Distribution of Controlled Substances and Financial Crimes (March 09, 2023)

Indiana Man Sentenced to 5 Years' Probation for Obtaining a Controlled Substance by Deception (March 08, 2023)

Laurence Doud, Former CEO of Pharmaceutical Distributor, Sentenced to 27 Months in Prison for Conspiring to Unlawfully Distribute Controlled Substances and Defrauding the DEA (March 08, 2023)

Pain Clinic Owners Sentenced for Unlawfully Distributing Opioids and Multimillion-Dollar Health Care Fraud (March 7, 2023)

Westmoreland County Doctor Charged with Illegal Prescribing and Fraud (March 1, 2023)

February 2023

DOJ and Lincoln Pharmacy in Tacoma Settle Allegations the Pharmacy Failed to Follow the Controlled Substances Act (February 28, 2023)

Physician Agrees to $190,731 Settlement Relating to Controlled Substances Act Claims (February 24, 2023)

Queens Pharmacist Pleads Guilty to Illegally Distributing Oxycodone and Filing False Tax Returns (February 17, 2023)

Former Office Manager of New Jersey Medical Practice Admits Conspiring with Doctor to Divert Controlled Substances (February 15, 2023)

Madison Heights Pharmacist Sentenced for Diverting Over 25,000 Opioid Pills (February 9, 2023)

Missouri Doctor Admits Diluting Clinic’s Methadone (February 03, 2023)

Nine Arrested for Illegally Distributing 1.5 Million Opioid Pills (February 2, 2023)

January 2023

Medical Director of Baltimore County Pain Management Clinic Sentenced for Conspiracy to Distribute and Dispense Oxycodone (Jan. 24, 2023)

Chester County Doctor Pleads Guilty to Operating Pill Mill Out of Main Line Pain Clinic (Jan. 20, 2023)

South Florida Doctor Sentenced to Prison for Unlawfully Dispensing Narcotics (Jan. 11, 2023)

Former Doctor Convicted of Illegal Distribution of Controlled Substances (Jan. 11, 2023)

Savitz Drug Store to Pay $275,000 to Resolve Alleged Controlled Substance Act Violations (Jan. 6, 2023)

December 2022

Department of Justice Files Nationwide Lawsuit Against Amerisource Bergen Corp. and Subsidiaries for Controlled Substances Act Violations (Dec. 29, 2022)

Bethlehem Company Agrees to Pay $230,000 to Resolve Allegations It Failed to Notify the DEA and Maintain Required Records Regarding Chemical Transactions (Dec. 20, 2022)

Doctor and Office Manager Indicted in Scheme to Defraud Medicare, Manufacture and Distribute Fentanyl (Dec. 16, 2022)

DEA Serves Order to Show Cause on Truepill Pharmacy for its Involvement in the Unlawful Dispensing of Prescription Stimulants (Dec. 15, 2022)

Long Island Medical Doctor Charged with Illegally Distributing Oxycodone Pills (Dec. 14, 2022)

Doctor and Eight Others Charged with Distributing Opioids and Other Pills (Dec. 9, 2022)

Pike County Physician Convicted for Unlawful Distribution of Controlled Substances Resulting in Death (Dec. 8, 2022)

Emergency Disaster Relief
Search for Year Round Pharmaceutical Disposal Locations.
National Prescription Drug Take Back Day. Turn in your unused or expired medication for safe disposal here.
RX Abuse Online

U.S. DEPARTMENT OF JUSTICE  •  DRUG ENFORCEMENT ADMINISTRATION
Diversion Control Division  •  8701 Morrissette Drive  •  Springfield, VA 22152  •  1-800-882-9539

DOJ Legal Policies and Disclaimers    |    DOJ Privacy Policy    |    FOIA    |    Section 508 Accessibility